A Bayesian Dose Finding Design for Oncology Clinical Trials of Combinational Biological Agents

Journal of the Royal Statistical Society. Series C: Applied Statistics - United Kingdom
doi 10.1111/rssc.12039
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Bayesian Dose-Finding Design for Drug Combination Clinical Trials Based on the Logistic Model

Pharmaceutical Statistics
StatisticsProbabilityPharmacology
2014English

A Bayesian Dose Finding Design for Clinical Trials Combining a Cytotoxic Agent With a Molecularly Targeted Agent

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2014English

A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials

Journal of the Royal Statistical Society. Series C: Applied Statistics
UncertaintyStatisticsProbability
2015English

Two Stage Adaptive Optimal Design With Applications to Dose-Finding Clinical Trials

English

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

Dose Titration Algorithm Tuning (DTAT) Should Supersede ‘The’ Maximum Tolerated Dose (MTD) in Oncology Dose-Finding Trials

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2017English

A Bayesian Dose-Finding Design Incorporating Toxicity Data From Multiple Treatment Cycles

Statistics in Medicine
EpidemiologyStatisticsProbability
2016English

Adaptive Dose Finding Based Ont-Statistic for Dose–response Trials

Statistics in Medicine
EpidemiologyStatisticsProbability
2008English

Characteristics of Oncology Clinical Trials

JAMA Internal Medicine
Internal Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy